Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical features and prognostic value of TP53 mutation in Chinese prostate cancer patients].

Zhonghua wai ke za zhi [Chinese journal of surgery] - 1 Nov 2021

Zhang T W, Wei Y, Pan J, Fang B W, Ye D W, Zhu Y

Abstract excerpt

Objective: To examine the clinical features and prognostic value of TP53 mutation in circulating tumor DNA(ctDNA) of Chinese prostate cancer patients. Methods: A prospective cohort of 239 prostate cancer patients diagnosed in the Department of Urology, Fudan University Shanghai Cancer Center from May 2018 to June 2019 was included. The age of diagnosis was(65.4±7.6) years(range: 45 to 85 years). Clinical data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Androgen Antagonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Prostatic Neoplasms, Castration-Resistant

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 34743450
DOI: 10.3760/cma.j.cn112139-20210715-00312

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical features and prognostic value of TP53 mutation in Chinese prostate cancer patients].PMID 34743450Read ↗

TP53 Deficiency in the Natural History of Prostate CancerSemantic proximity Read ↗

Evaluation of the Prognostic Role of TP53 Gene Mutations in Prostate Cancer Outcome: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study.Semantic proximity Read ↗

Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer.Semantic proximity Read ↗

Genetic features of TP53 mutation and its downstream FOXA1 in prostate cancer.Semantic proximity Read ↗

The Current Status of Comprehensive Genomic Profiling in the Management of Metastatic Castration-Resistant Prostate Cancer: A Study from a Cooperative Hospital for Cancer Genomic Medicine in Japan.Semantic proximity Read ↗

TP53 alterations of hormone-naïve prostate cancer in the Chinese population.Semantic proximity Read ↗

Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity.Semantic proximity Read ↗

[Prostate cancer with BRCA2 pathogenic mutation: a clinicopathological analysis].Semantic proximity Read ↗

Prognostic Significance of Circulating Tumor DNA in Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Germline mutations of TP53 gene can be a key factor in prostate cancer genesisSemantic proximity Read ↗

Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.